Oxford/AstraZeneca Covid vaccine 80% effective against B1.617.2 variant: Study

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly...